Analyze Diet
Research in veterinary science2013; 96(1); 147-152; doi: 10.1016/j.rvsc.2013.12.007

Naproxen in the horse: pharmacokinetics and side effects in the elderly.

Abstract: It is well-known that old animals show physiologic and/or pathologic variation that could modify the pharmacokinetics of drugs and the related pharmacodynamic response. In order to define the most appropriate therapeutic protocol in old horses, pharmacokinetic profile and safety of naproxen were investigated in horses aged over 18 years after oral administration for 5 days at the dose of 10 mg/kg b.w./day. After the first administration, the maximum concentration (Cmax 44.21 ± 9.21 μg/mL) was reached at 2.5 ± 0.58 h post-treatment, the harmonic mean terminal half-life was 6.96 ± 1.73 h, AUC0-24h was 459.71 ± 69.95 h μg/mL, MRT was 7.44 ± 0.74 h and protein binding was 98.47 ± 2.72%. No drug accumulation occurred with repeated administrations. No clinical and laboratory changes were detected after administration of naproxen. Gastric endoscopies performed after the treatment did not show pathological changes of the gastric mucosa.
Publication Date: 2013-12-14 PubMed ID: 24388762DOI: 10.1016/j.rvsc.2013.12.007Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the pharmacokinetics (how a drug is absorbed, distributed, metabolized, and excreted) and side effects of the drug naproxen in older horses over a span of 5 days. The study indicates that naproxen was well-tolerated with no side effects or changes in gastric tissue observed.

Study Design and Methods

  • The study was conducted on horses aged 18 years and older, the group that can often show physiological and pathological changes which can affect drug response.
  • The drug, naproxen, was administered orally at a dose of 10 mg/kg body weight per day for 5 days.
  • The researchers focused on various indicators to measure drug absorption and metabolism. These included the maximum concentration of the drug in the body (Cmax), the time it took to reach that concentration, the mean terminal half-life of the drug (amount of time for the concentration to drop by half), the area under the concentration-time curve (AUC), mean residence time (MRT), and the level of protein binding.

Results

  • The maximum concentration of naproxen was reached approximately 2.5 hours after treatment, with the harmonic mean terminal half-life noted to be around 6.96 hours.
  • The study noted an AUC of 459.71 ± 69.95 h μg/mL, indicating the total drug exposure over time, and an MRT of 7.44 ± 0.74 h, indicating the average time the drug stays in the body.
  • High protein binding of 98.47 ± 2.72% was reported. Protein binding is the drug’s ability to bind to proteins in the blood, particularly albumin, and influences a drug’s pharmacokinetics.
  • Interestingly, no drug accumulation occurred with repeated administrations, highlighting the body’s ability to efficiently metabolize and excrete the drug.

Safety and Side Effects

  • After naproxen administration, no clinical and laboratory changes were detected, suggesting that the drug was well-tolerated in the studied horses.
  • Moreover, gastric endoscopies were performed post-treatment and no pathological changes were observed in the gastric mucosa, which is a notable finding given that non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen can often cause gastrointestinal side effects.

Cite This Article

APA
Della Rocca G, Di Salvo A, Cagnardi P, Marchesi MC, Conti MB. (2013). Naproxen in the horse: pharmacokinetics and side effects in the elderly. Res Vet Sci, 96(1), 147-152. https://doi.org/10.1016/j.rvsc.2013.12.007

Publication

ISSN: 1532-2661
NlmUniqueID: 0401300
Country: England
Language: English
Volume: 96
Issue: 1
Pages: 147-152

Researcher Affiliations

Della Rocca, G
  • Dept. of Veterinary Pathology, Diagnostic and Clinics, University of Perugia, Via S. Costanzo 4, 06100 Perugia, Italy. Electronic address: giorgia.dellarocca@unipg.it.
Di Salvo, A
  • Dept. of Veterinary Pathology, Diagnostic and Clinics, University of Perugia, Via S. Costanzo 4, 06100 Perugia, Italy.
Cagnardi, P
  • Dept. of Health, Animal Science and Food Safety, Università degli Studi di Milano, Via Celoria 10, 20133 Milano, Italy.
Marchesi, M C
  • Dept. of Veterinary Pathology, Diagnostic and Clinics, University of Perugia, Via S. Costanzo 4, 06100 Perugia, Italy.
Conti, M B
  • Dept. of Veterinary Pathology, Diagnostic and Clinics, University of Perugia, Via S. Costanzo 4, 06100 Perugia, Italy.

MeSH Terms

  • Administration, Oral
  • Animals
  • Area Under Curve
  • Female
  • Gastric Mucosa / metabolism
  • Half-Life
  • Horses / metabolism
  • Naproxen / administration & dosage
  • Naproxen / pharmacology

Citations

This article has been cited 1 times.
  1. Ilyas S, Jilani K, Sikandar M, Siddiq S, Riaz M, Naveed A, Bibi I, Nawaz H, Irfan M, Asghar A. Stimulation of Erythrocyte Membrane Blebbing by Naproxen Sodium. Dose Response 2020 Jan-Mar;18(1):1559325819899259.
    doi: 10.1177/1559325819899259pubmed: 31983907google scholar: lookup